S2G Investments — 2018 Investments
2 investments dated 2018 · listed companies and verified rows first · show all
Confluence Genetics (operating at bensonhillbio.com) is a seed innovation company that develops soybean genetics using AI-driven plant science and proprietary tools such as eMERGE Genetics and CropOS.
Durham, US
Matthew B Crisp(Executive Officer, Director)Lee Palles(Executive Officer)inNadine Carozzi(Executive Officer)Todd C Mockler(Executive Officer)Thomas Brutnell(Executive Officer)
BoardDaniel J Broderick(Director)
Co-investorsActivant CapitalAlexandriaBioGenerator VenturesCultivation CapitalFall Line CapitalGV (Google Ventures)+6 more
UCAN produces sports nutrition products powered by LIVSTEADY, a proprietary low-glycemic carbohydrate formulation designed to deliver sustained energy without rapid blood sugar spikes.
BiotechConsumerDirect to ConsumerFoodTechHealthtechWellness & FitnessWoodbridge, US
Shoba Murali(Executive Officer, Director, Promoter)inDavid Feldman(Executive Officer, Director, Promoter)Ramesh Ratan(Executive Officer)Peter Kaufman(Executive Officer, Director, Promoter)in
BoardStephen Squinto, Sr.(Director)Kannankote (Sri) Srikanth(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


